← All trials
NCT01425749
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 1, 2011
- Primary completion
- Jul 1, 2013
- Completion date
- Oct 1, 2015
- First posted
- —
- Last posted
- —
- Enrollment
- 25
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- University of VirginiaLead sponsor
- University of VirginiaOverall official - principal investigator
- University of VirginiaSponsor investigator
- GlaxoSmithKlineCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.